SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
As a multi-entity complex senior services and healthcare organization, we were looking for an interim CFO to help us with what we anticipated would be a six-month transition. Frank Tsaiwas a great fit with our agency and a wonderful partner to the CEO and other C-level leaders. The totality of his extensive healthcare finance expertise allowed him to hit the ground running to support the complexity and breadth of services for our organization. As interim CFO, Frank significantly enhanced our planning and financial processes, enabling us to achieve our enrollment growth and topline goals that had been elusive for many years. He quickly added value drawing on his deep knowledge of nonprofits, managed care, senior living and senior health care. He brought an analytical perspective that improved how we view and manage performance and impact. He also brought a warmth and ease that was an invitation to collaborate and an openness to change. His peers and his direct staff appreciated his energy, insight and work style. His leadership and expertise were invaluable to the organization and has set us on a path for greater success for the future. His original six-month timeline extended to almost a full year, and his impact will be long lasting.